Company intelligence / Profile preview

Futerro

Ownership: Private
Development stage: Commercial

Overview

Futerro commercially produces high-quality PLA biopolymers under the RENEW™ brand with an annual capacity of up to 100,000 tons. It leads in closed-loop sustainability with its patented LOOPLA® process that enables nearly complete chemical recycling of PLA back to lactic acid. The company has established itself as a global leader in sustainable plastics innovation and holds over 250 patents.

Industry: Chemicals & Materials

Partnerships

K.D. Feddersen Group – distribution agreement for RENEW™ products across EuropeAnhui BBCA Biochemical CO., LTD. – joint venture partner for Chinese operations

Beyond the preview

Go deeper on Futerro.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Futerro.

Explore the full profile